Procurement Summary
State : Uttar Pradesh
Summary : Inj. Ranibizumab 2.3 Mg/0.23 Ml
Deadline : 13 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 103898056
Document Ref. No. : 12245132
Competition : NCB
Financier : Self Financed
Purchaser Ownership : Public
Document Fees : Refer Document
Tender Value : Refer Document
EMD : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Inj. Ranibizumab (Each PFS/ Amp/Vial contains Ranibizumab upto 2.3 mg/ 0.23 ml) {The drug sho uld be DGCI approved for Diabetic Macular oedema, Retinal vein occlusion, Proliferative Diabetic Retinopathy, R etinopathy of Prematurity and Myopic Choroidal Neovascular Membrane.} [ Warranty Period: 30 Months after th e date of delivery ]
Contract Category: Expenditure
Contract Type : Goods
Tender Type : Limited - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : 12
Inspection Agency : CONSIGNEE
Publishing Date / Time : 09/07/2024 12:36
Procure From Approved Sources : No
Approving Agency : Not Applicable
Closing Date Time : 13/07/2024 11:30
Validity of Offer ( Days) : 60
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00
Consignee Ch.Ph/CD Store/GKP, NER Uttar Pradesh 2.00 Numbers
Documents
Tender Notice
viewNitPdf_4635354.pdf